Quadriplegia Treatment Market Segment Overview, Regional Analysis and Forecast to 2032Posted by Ganesh Shinde on April 17th, 2023  The Global Quadriplegia Treatment Market is expected to be worth US$ 1,468.4 million in 2022. The global market for quadriplegia therapy is expected to reach ,324.4 million by 2032, rising at a 4.7% CAGR between 2022 and 2032. The need for quadriplegia treatment will gradually increase, providing manufacturers with various promising development opportunities in the near future. Key Drivers of Quadriplegia Treatment Market Quadriplegia, often known as tetraplegia, is a spinal cord injury caused by trauma to the base of the neck or head. Accidents, spinal cord tumours, and other spinal cord disorders can all cause spinal cord injuries. Such injuries can result in limb paralysis, either partial or total. According to the 2020 Spinal Cord Injury Statistics data sheet, it is predicted that around 17,810 new cases of spinal cord injuries occur in the United States each year. Stroke, vehicular accidents, falls, violence, sports, medical or surgical causes, and others are some of the most common causes of quadriplegia. In June 2021, the World Health Organisation (WHO) claimed that 20-50 million individuals are injured in road traffic accidents each year, with non-fatal injuries but lasting disability. With the rising number of traffic accidents, demand for quadriplegia treatment is likely to rise during the predicted period. Key player of Quadriplegia Treatment Market Major manufacturers of medications needed to treat quadriplegia are
Browse Detail Summary@ https://www.futuremarketinsights.com/reports/quadriplegia-treatment-market Key Segments By Treatment Type:
By Route of Administration:
By Distribution Channel:
Like it? Share it! More by this author |